Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

856 questions in 87 reviews · Cystic Fibrosis and Genetic Disorders

current versions
No studies 856 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Summary of findings: nitric oxide vs placebo
Inflammatory markers · children (12 or over) and young adults with cystic fibrosis
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Zinc supplementation vs placebo
QoL · children with cystic fibrosis
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Zinc supplementation vs placebo
Sputum microbiology · children with cystic fibrosis
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Zinc supplementation vs placebo
Inflammatory markers · children with cystic fibrosis
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: β‐carotene vs placebo
Need for antibiotics see pulmonary exacerbations · children and adults with cystic fibrosis
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: β‐carotene vs placebo
QoL · children and adults with cystic fibrosis
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: β‐carotene vs placebo
Sputum microbiology · children and adults with cystic fibrosis
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: β‐carotene vs placebo
Inflammatory markers · children and adults with cystic fibrosis
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: garlic supplementation vs placebo
Pulmonary exacerbations · children aged over eight and adults with cystic fibrosis and chronic pulmonary infection with P aeruginosa
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECT
Change in BMI · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECT
Adverse events · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECT
Pulmonary exacerbations · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECMM
Change in weight · children with cystic fibrosis and proven pancreatic insufficiency
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECMM
Change in height · children with cystic fibrosis and proven pancreatic insufficiency
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECMM
Change in BMI · children with cystic fibrosis and proven pancreatic insufficiency
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs NECT plus cimetidine
Change in height · adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECMM
Adverse events · children with cystic fibrosis and proven pancreatic insufficiency
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECMM
Pulmonary exacerbations · children with cystic fibrosis and proven pancreatic insufficiency
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM (Creon®) vs a different ECM
Change in height · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM (Creon®) vs a different ECM
Change in BMI · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM (Creon®) vs a different ECM
Pulmonary exacerbations · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs NECT plus cimetidine
Change in BMI · adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs TPE
Change in height · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs TPE
Change in BMI · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs TPE
Frequency of bowel symptoms · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs TPE
Adverse events · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs TPE
Pulmonary exacerbations · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs other enteric‐coated preparations
Change in BMI · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs other enteric‐coated preparations
Adverse events · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs other enteric‐coated preparations
Pulmonary exacerbations · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: low‐dose vs high‐dose PERT
Change in height · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: low‐dose vs high‐dose PERT
Change in BMI · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: low‐dose vs high‐dose PERT
Pulmonary exacerbations · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: liprotamase vs porcine PERT
Change in height · children aged 7 years or over and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: liprotamase vs porcine PERT
Change in BMI · children aged 7 years or over and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs NECT plus cimetidine
Adverse events · adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs NECT plus cimetidine
Pulmonary exacerbations · adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECT
Change in height · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Pine bark extract vs placebo
Participant‐reported · children and adults with asthma diagnosed by American Thoracic Society criteria
Pine bark (Pinus spp.) extract for treating chronic disorders (2020) · Cochrane
no estimate extractedNRNo studies
Pine bark extract vs placebo
Investigator‐reported · children with ADHD
Pine bark (Pinus spp.) extract for treating chronic disorders (2020) · Cochrane
no estimate extractedNRNo studies
Pine bark extract vs placebo
All‐cause mortality · children with ADHD
Pine bark (Pinus spp.) extract for treating chronic disorders (2020) · Cochrane
no estimate extractedNRNo studies
Pine bark extract vs placebo
Serious adverse events · children with ADHD
Pine bark (Pinus spp.) extract for treating chronic disorders (2020) · Cochrane
no estimate extractedNRNo studies
Pine bark extract vs placebo
Participant‐reported · adults with CVD
Pine bark (Pinus spp.) extract for treating chronic disorders (2020) · Cochrane
no estimate extractedNRNo studies
Pine bark extract vs placebo
Investigator‐reported · adults with CVD
Pine bark (Pinus spp.) extract for treating chronic disorders (2020) · Cochrane
no estimate extractedNRNo studies
Pine bark extract vs placebo
All‐cause mortality · adults with CVD
Pine bark (Pinus spp.) extract for treating chronic disorders (2020) · Cochrane
no estimate extractedNRNo studies
Pine bark extract vs placebo
Participant‐reported · adults with CVI
Pine bark (Pinus spp.) extract for treating chronic disorders (2020) · Cochrane
no estimate extractedNRNo studies
Pine bark extract vs placebo
Investigator‐reported · adults with CVI
Pine bark (Pinus spp.) extract for treating chronic disorders (2020) · Cochrane
no estimate extractedNRNo studies
Pine bark extract vs placebo
All‐cause mortality · adults with CVI
Pine bark (Pinus spp.) extract for treating chronic disorders (2020) · Cochrane
no estimate extractedNRNo studies
Pine bark extract vs placebo
Serious adverse events · adults with CVI
Pine bark (Pinus spp.) extract for treating chronic disorders (2020) · Cochrane
no estimate extractedNRNo studies
Pine bark extract vs control
Participant‐reported · adults with diabetes mellitus type I
Pine bark (Pinus spp.) extract for treating chronic disorders (2020) · Cochrane
no estimate extractedNRNo studies